日本心臓血管内視鏡学会 学会誌「心臓血管内視鏡(Angioscopy)」

Angioscopy Instructions for Authors

established on June 1, 2017

EDITORIAL POLICY

1. Aim of this journal

Angioscopy is the official journal of the Japanese Association of Cardioangioscopy (JACA).

Angiosocpy publishes original research related to angioscopy, including clinical studies, state-of-the-art technology, and basic sciences.

2. Qualification for submission

One of the authors of a manuscript submitted to Angioscopy should be a current member of the JACA, except in the case of invited article by the Editorial Board.

A submitted article to the JACA is original, also the article has not been published before and is not under consideration for publication elsewhere.

3. Manuscript type

The types for paper submissions are Review Articles, Original Articles, Brief Communication, Case Reports, Imaging Sessions, and other invited articles.

4. Peer-review process

Angioscopy applies single-blind peer review process by at least two referees selected by the Editorial Board member. Based on the judgments of the referees, the Editorial Board will make one of the following decisions: Acceptance; Conditional acceptance; Rejection.

5.Copyright

All published articles become the property of the JACA with all rights reserved. Authors’ agreement should be declared by submitting the “Authorship Agreement and Copyright Transfer Form” (form 1) at the time of submission.

The article may not infringe on the copyright of other articles. Permission should be obtained by authors beforehand if necessary.

6.Authorship

Authors have to meet all the criteria below, which are defined by ICMJE (International Committee of Medical Journal Editors).Anyone who meets all the criteria below must be listed as an author.

  1. Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work.
  2. Drafting the work or revising it critically for important intellectual content.
  3. Final approval of the version to be published.
  4. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Those who do not meet the four criteria should be acknowledged.

7.Conflict of interest

When submitting a manuscript, all authors, and their spouse or other immediate family, are required to disclose any financial or personal relationship with a biotechnology manufacturer, a pharmaceutical company, or other commercial entity that has an interest in the subject matter or materials discussed in the manuscript, within the period of 12 months prior to the submission.

All disclosures should be disclosed by both below:

  1. Submitting the “Conflict of Interest Disclosure Statement” (form 2) at the time of submission.
  2. Describe in the “Disclosure” section before “References” section in the text as shown in the following example.
    [Example of a disclosure statement]
    • A (author name) serves as a consultant to Z (entity name);
    • B received a research grant from Y;
    • C received lecture fees from X;
    • D holds a patent on V;
    • E has been reimbursed by U for attending several conferences;
    • F received honoraria for writing promotional material for T;
    • G has no conflict of interest.

8.Ethics Policy

All authors are expected to abide by the Helsinki declaration. In the case of human subjects, informed consent is essential, in addition, authors should provide an explicit statement in Methods that the research was approved by the appropriate ethical committee, and carefully attempt to protect the patient's identities and privacy.

MANUSCRIPT PREPARATION

9.Languages

A manuscript should be prepared in English.

10.Length

Manuscripts should conform to the length specified in the following items. The word limit or the printed pages includes references and tables/figures.

Review Article

Words:
Up to 4500 words (6 printed pages including tables/figures)
Abstract:
Up to 250 words
Structure:
Free style, followed by (Acknowledgment), Disclosure Statement, References, and Legends
Table/Figure:
Up to 8

Original Article

Words:
Up to 4500 words (6 printed pages including tables/figures)
Abstract:
Up to 250 words
Structure:
Abstract, Introduction, Material and Methods, Results, Discussion, Conclusion, (Acknowledgment), Disclosure Statement, References, and Legends
Table/Figure:
Up to 8

Case Report

Words:
Up to 3000 words (4 printed pages including tables/figures)
Abstract:
Up to 250 words
Structure:
Abstract, Introduction, Case presentation, Discussion, (Acknowledgment), Disclosure Statement, References, and Legends
Table/Figure:
Up to 8

Brief Communication

Words:
Up to 2000 words (2 printed pages including tables/figures)
Abstract:
Up to 200 words
Structure:
Abstract, Introduction, Material and Methods, Results, Discussion, Conclusion, (Acknowledgment), Disclosure Statement, References, and Legends
Table/Figure:
Up to 2

Imaging Session

Words:
Up to 2000 words (2 printed pages including tables/figures)
Abstract:
Up to 200 words
Structure:
Free style (showing primarily images with minimal text), followed by (Acknowledgment), Disclosure Statement, References, and Legends
Table/Figure:
No limit

11.File formats

Manuscript files should be saved in the formats below.

  1. Title page and Text (abstract – Legends): Word
  2. Tables: Word, Excel or PowerPoint (image data is unacceptable)
  3. Figures: PowerPoint, PDF (Contribution of supplementary movie file is strongly recommended)
  4. Authorship Agreement and Copyright Transfer Form and COI form: PDF

12.Title page

The title page should include the following information.

  1. Manuscript type (Review Article, Original Article, Case Report, Image Session)
  2. Title
  3. Running Title (up to 12 words)
  4. All authors' names (first name, middle initial[s], last name) with academic degrees and JACA Membership Number (if applicable)
  5. All authors' institutional affiliations (where the manuscript has been created)
  6. Contact details of the corresponding author (mailing address, telephone number, and email address)

13.Basic structure of manuscripts

After the title page, arrange the manuscript in the order of Abstract, Keywords (within 5 words), Text, (Acknowledgement), Disclosure Statement, References, Legends, Tables, and Figures.

14.Numerals and units

Use Arabic numerals and SI units.

15.Abbreviation

Abbreviation should be spelled out in the first appearance in each part of title, abstract, key words, and text. In legends of tables and figures, abbreviations should be defined for each table and figure.

16.References

References are to be listed in the order cited in the text. References cited in the text should be indicated by consecutive superscript numbers.

The structure for a journal article is: author(s), title of paper, journal name (abbreviated as in Index Medicus or written in full if no abbreviation quoted), year of publication, volume number, first and last pages. The structure for a book is: author(s), title, book title, editor(s) or compiler(s), edition number, publisher’s name and place of publication, year of publication, first and last pages (if relevant). The structure for an online material is: website publisher, title of cited page, URL in full, the date when the reference was last accessed. In the reference list, if authors are more than 4, list the first 3 followed by “et al”. If there are three authors or less, list all of their names.

[Examples of reference style]

Journal article: Endo M, Hirosawa K, Kaneko N, et al: Prinzmetal’s variant angina: Coronary arteriogram and left ventriculogram during angina attack induced by methacholine. N Engl J Med 1976; 294: 252–255

Book: Everson C, Mills N: The inferior epigastric artery. Alternative Bypass Conduits and Methods for Surgical Coronary Revascularization, ed by Grooters RK, Nishida H, 2nd Ed, Futura, New York, 1994, 73–80

Online Material: U.S. Food and Drug Administration. FDA Drug Safety Communication: Pradaxa (dabigatran etexilate mesylate) should not be used in patients with mechanical prosthetic heart valves. http://www.fda.gov/Drugs/DrugSafety/ucm332912.htm (Accessed Sep. 23. 2016)

17.Supplementary Information

Supplementary video files are acceptable and can be published on-line journal J-STAGE along with the article. Each video file should be provided a title and mentioned in the text as shown in Appendix 1 for example. Authors have to send the video files at the time of submission abided by following rules:

  • Video files do not invade anyone’s copyright otherwise violate any statutory or common law right of anyone.
  • Supplementary information must be up to 5 files, and each file should not exceed 10 MB.
  • Acceptable file formats are AVI (.avi),MPEG (.mpg),QuickTime (.mov),and WMV (.wmv).

18.Submission

A manuscript should be sent as email attachments to the Editorial Office at: angioscopy@medical-tribune.co.jp.

Authors should resubmit the manuscript within three months from the editorial decision. If authors require additional time, please notify the editorial office by the deadline.

PROOF AND PUBLICATION CHARGE

19.Proof

After correction for English grammar, the galley proofs will be sent to the authors of accepted manuscripts for final proofreading. Please check these for spelling, punctuation, and overall accuracy.

20.Publication charge

The number of pages for publication should be limited in accordance to the article types. In case the number of pages exceeds the above limitation, authors have to pay extra page charge (20,000 JPY per each extra page).

Offprint should be ordered at the galley proof correction stage. Authors cover the costs of extra page and offprints.

Inquiry to: Angioscopy Editorial Office

Scientific Journal Publishing Department, Medical Tribune, Inc.
Toranomon 33 Mori Bldg. 7F, 3-8-21, Toranomon, Minato-ku, Tokyo 105-0001, Japan
TEL: 03-6841-4555, E-Mail: angioscopy@medical-tribune.co.jp

Download links
Authorship agreement
Conflict of interest disclosure statement